Dr. Su Wang has been appointed WHA President-elect, having served on the executive board of the WHA since 2014 as a regional representative for the PAHO region. Su is an internal medicine physician who discovered she had hepatitis B after donating blood in college and has used her own personal experience to advocate for the elimination of hepatitis. She worked for many years in New York City leading outreach and care programmes for hepatitis B patients and now directs a number of hepatitis B and C programmes in her current role as Medical Director for the Center for Asian Health at Saint Barnabas Medical Center in New Jersey .
Earlier this month Dr Wang presented a lecture at the EASL/AASLD meeting in London, highlighting the perspectives of people living with hepatitis B. The lecture which was part of the plenary session on Clinical Trials Aimed at HBV Cure can be viewed here.
“Su has a long history of championing hepatitis B care in underserved populations and has been a strong advocate of expanding hepatitis B and C services to frontline providers. She is a well-respected leader in the field and has also been an integral part of developing our NOhep Medical Visionaries programme. She is also a good friend.” said Michael Ninburg.
Dr. Wang added, “I am honored to have this opportunity to serve as President and continue the great work of the Alliance in moving us towards elimination by 2030.”
As President-elect, she will shadow current President Michael Ninburg until January 2020, when she will take up the role of President.
"I am thrilled with this next generation of leadership at the Alliance. We are well positioned for the next chapter in the race to eliminate viral hepatitis” said WHA President Michael Ninburg.